Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis

Neovascular eye diseases including retinopathy of prematurity, diabetic retinopathy and age-related-macular-degeneration are major causes of blindness. Fenofibrate treatment in type 2 diabetes patients reduces progression of diabetic retinopathy independent of its peroxisome proliferator-activated r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EBioMedicine
Autors principals: Gong, Yan, Shao, Zhuo, Fu, Zhongjie, Edin, Matthew L., Sun, Ye, Liegl, Raffael G., Wang, Zhongxiao, Liu, Chi-Hsiu, Burnim, Samuel B., Meng, Steven S., Lih, Fred B., SanGiovanni, John Paul, Zeldin, Darryl C., Hellström, Ann, Smith, Lois E.H.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5264653/
https://ncbi.nlm.nih.gov/pubmed/27720395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.09.025
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars